#IDIBELLfellows: Júlia Migó
Role of S100A9 in tumor cell plasticity in breast cancer Júlia Migó – Gynecologic cancer group Advanced…
International Open Access Week 2022 – Webinars
-
from 24 to 30 October
#IDIBELLfellows: Romina Miranda / Marta Valle
07/10/2020 15:00-16:00
Room 205 – Nou aulari UB-Bellvitge
Microsoft Teams Meeting
#IDIBELLconnect: Novel clinical and translational research approaches to mesothelioma, an orphan tumor
Ernest Nadal
Group Leader at Bellvitge Biomedical Research Institute (IDIBELL), Clinical Research in Solid Tumors Group, Oncobell Program
Head of Section of Thoracic, Brain and Head and Neck Tumors, Catalan Institute of Oncology (ICO), Department of Medical Oncology
Associate Professor, University of Barcelona, Department of Clinical Sciences, Campus Bellvitge
09/10/2020 13:00-14:00
Microsoft Teams Meeting
Career Day 2020
21/10/2020 -
21-22 October 2020
This event is being held online
La recerca en temps de pandèmia
Dra. Maria Ángeles Domínguez
Dr. Xavier Solanich
21/10/2020 19:00-
VII Programa de excelencia en el abordaje del paciente con EM de alta actividad
Unitat EM HUB
22/10/2020 -
22-23 Octubre 2020
Sala d’actes Bellvitge University hospital 9.00h
#IDIBELLconnect: RANK a novel therapeutic target in breast cancer
Speaker Eva Gonzalez-Suarez
Transformation and Metastasis Group, Oncobell Program
06/11/2020 13:00-14:00
PhD Day 2020
12/11/2020 -
12-13 November 2020
this event is being held online
#IDIBELLconnect: Generation of protective immunity against infections by removing non-neutralizing/blocking antibodies
Rafael Máñez
Group Leader at the Bellvitge Biomedical Research Institute (IDIBELL), Innate Immunity and Pathology of the Critical Patient Group, Infectious disease and transplantation Program
Director of Intensive Care Department at Bellvitge University Hospital
20/11/2020 13:00-14:00
Microsoft Teams Meeting
Thesis: Osteoarticular infections: insights on bacteraemic clinical forms and antimicrobial alternatives against Pseudomonas aeruginosa from a translational perspective
By Joan Gómez Junyent
Directors: Javier Ariza Cardenal i Oscar Murillo Rubio
24/11/2020 12:00-
Xerrades Sinergia
Òscar Martínez Tirado
Marta Barrachina
Gabriela Jiménez
Anna Veiga
Esteve Fernandez
Susana Jiménez
Rafael Máñez
Mònica Povedano
Miquel Àngel Pujana
Laia Alemany
Montse Nacher
28/11/2020 10:00-19:00
Online i en directe:
https://sinergia.l-h.cat/
#IDIBELLconnect: The mTOR-LARP1 axis and the anabolic reservoir of tumor cells: A new therapeutic target in colorectal cancer and beyond
Antonio Gentilella
Metabolism and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL)
Department of Physiology and Biochemistry, Faculty of Pharmacy, University of Barcelona
04/12/2020 13:00-14:00
Microsoft Teams Meeting
#IDIBELLconnect: Immunotherapeutic potential of oncolytic Vaccinia viruses
Juan Jose Rojas
Bellvitge Biomedical Research Institute (IDIBELL)
Unitat d’Immunologia, Departament de Patologia i Terapèutica Experimental, Universitat de Barcelona
18/12/2020 13:00-14:00
Microsoft Teams Meeting
- 1
- 2
- 3
- …
- 28
- Entrades següents »
Epithelial to mesenchymal transition controls intra-tumour heterogeneity and segregation of labour in breast cancer
Special Seminar Friday, July 12th. 13:00 Sala d’Actes, Pavelló de Govern 1a planta Epithelial to mesenchymal transition…
#IDIBELLfellows: Laura Casado Medina / Lidia Collado Rodríguez
3D Bioprinted Tubular Cardiac Tissues as a Tool for Cardiac Therapies Laura Casado Medina – Stem Cell…
Monòlegs científics Stand-up Science
Dins la programació Summer Experience L’Hospitalet, els investigadors més joves de l’IDIBELL faran els seus monòlegs científics…
Thesis: H3K9 methylation in haematopoietic stem cell aging and leukaemia
H3K9 methylation in haematopoietic stem cell aging and leukaemia Barbara Walter – Stem Cell Aging Group Universitat…
RegenBell 2024 symposium on Stem Cells and Regenerative Medicine
RegenBell is proud to announce the RegenBell 2024 Symposium on Stem Cells and Regenerative Medicine with the…
#IDIBELLfellows: Ana Amaya Garrido / Marcel Schilling
Exploring Cdc42 as a novel therapeutic target to promote resistance to ischemia/reperfusion injury in aging kidneys Ana…
Constitutional epimutations in hereditary cancer predisposition
Megan Hitchins – Department of Biomedical Sciences, Cedars-Sinai Medical Center Dr. Megan Hitchins undertakes translational cancer research…
An Overview of the Increasing Incidence and Possible Causes of Early Onset Colorectal Cancer
Robert Haile – Department of Biomedical Sciences, Cedars-Sinai Medical Center. The research focus of Dr. Robert Haile…
Thesis: Re-definition of non-small cell lung cancer transcriptional subtypes using integrative bioinformatics approaches
Thesis: Re-definition of non-small cell lung cancer transcriptional subtypes using integrative bioinformatics approaches By Sara Hijazo Pechero…
- 1
- 2
- 3
- …
- 28
- Entrades següents »